Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation
- PMID: 7799450
- DOI: 10.1006/jmcc.1994.1116
Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation
Abstract
This study was undertaken to evaluate the direct cardioprotective effect of trimetazidine (TMZ), an anti-anginal drug devoid of haemodynamic action, on isolated myocytes. Cultured rat ventricular myocytes were treated with the drug 16 h and 1 h before the experiments. The drug-treated cells and control cells were placed in a substrate free medium and submitted in a specially designed device to either normoxia (N4), or hypoxia (150 min, H2.5, or 240 min, H4), or 150 min hypoxia followed by 90 min reoxygenation (HR). The treatment of the cells with TMZ (5 x 10(-4) M) resulted in a significant decrease of lactate dehydrogenase (LDH) leakage (-58% in H2.5, -36% in H4 and -37% in HR). The LDH release provoked by oxidizing agents. H2O2 and 13-s-HpOTrE (13(S)-hydroperoxyoctadecatrienoic acid) during post-hypoxic reoxygenation was also lowered by TMZ. However, this effect reflected the beneficial action of TMZ during hypoxia since the drug was not efficient in altering the LDH leakage induced by the oxidizing agents in normal conditions. Moreover, the hypoxia-induced decrease of ATP content was not affected by TMZ, and resynthesis of ATP during substrate-free reoxygenation was similar in TMZ-treated and control cells. The respiration parameters have been studied in rat heart mitochondria isolated from control and TMZ-treated rats, in the presence or absence of TMZ in the respiration medium (10(-4) M). The main result was a rapid and potent inhibition of palmitoylcarnitine oxidation, when TMZ was added to the respiration medium. The chronic treatment only resulted in a slight alteration of pyruvate oxidation. In conclusion, a pre-treatment of ventricular myocytes with TMZ resulted in an increased cell resistance to hypoxic stress, as evidenced by LDH leakage. This cytoprotective effect of TMZ should not be mediated through an antioxidant activity, but could be related to a modification of lipid metabolism.
Similar articles
-
Trimetazidine: in vitro influence on heart mitochondrial function.Am J Cardiol. 1995 Aug 24;76(6):31B-37B. Am J Cardiol. 1995. PMID: 7645525
-
Protective effects of trimetazidine on hypoxic cardiac myocytes from the rat.Fundam Clin Pharmacol. 1997;11(5):427-39. doi: 10.1111/j.1472-8206.1997.tb00205.x. Fundam Clin Pharmacol. 1997. PMID: 9342596
-
Endothelin-1 and phenylephrine-induced activation of the phosphoinositide cycle increases cell injury of cultured cardiomyocytes exposed to hypoxia/reoxygenation.J Mol Cell Cardiol. 1994 Nov;26(11):1513-24. doi: 10.1006/jmcc.1994.1170. J Mol Cell Cardiol. 1994. PMID: 7897674
-
Fatty acid oxidation in the heart.J Cardiovasc Pharmacol. 1996;28 Suppl 1:S11-7. doi: 10.1097/00005344-199600003-00003. J Cardiovasc Pharmacol. 1996. PMID: 8891866 Review.
-
Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review.Int J Mol Sci. 2024 Jan 28;25(3):1605. doi: 10.3390/ijms25031605. Int J Mol Sci. 2024. PMID: 38338885 Free PMC article. Review.
Cited by
-
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease.Medicine (Baltimore). 2015 Aug;94(33):e1161. doi: 10.1097/MD.0000000000001161. Medicine (Baltimore). 2015. PMID: 26287407 Free PMC article.
-
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine.Mol Psychiatry. 2023 Aug;28(8):3231-3242. doi: 10.1038/s41380-023-02134-8. Epub 2023 Jun 29. Mol Psychiatry. 2023. PMID: 37386057 Free PMC article. Review.
-
Updates on Pharmacologic Management of Microvascular Angina.Cardiovasc Ther. 2022 Oct 25;2022:6080258. doi: 10.1155/2022/6080258. eCollection 2022. Cardiovasc Ther. 2022. PMID: 36382021 Free PMC article. Review.
-
Trimetazidine has Promising Preventive Effects on Experimental Chronic Pancreatitis Rat Model.Turk J Gastroenterol. 2022 Apr;33(4):356-361. doi: 10.5152/tjg.2022.211153. Turk J Gastroenterol. 2022. PMID: 35550543 Free PMC article.
-
Modulating fatty acid oxidation in heart failure.Cardiovasc Res. 2011 May 1;90(2):202-9. doi: 10.1093/cvr/cvr038. Epub 2011 Feb 2. Cardiovasc Res. 2011. PMID: 21289012 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources